Andrew Oxtoby Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Oxtoby.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Oxtoby. Andrew Oxtoby is Chief Commercial Officer in Aimmune Therapeutics, Inc. ($AIMT).
Latest Insider Trading Transactions of Andrew Oxtoby
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | D | 23.81 | 67,500 | 1,607,175 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | D | 21.94 | 150,000 | 3,291,000 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Sell | D | 34.50 | 20,250 | 698,625 | 0 | 20.3 K to 0 (-100.00 %) |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Sell | U | 34.50 | 6,345 | 218,903 | 0 | 6.3 K to 0 (-100.00 %) |
| Sep 16 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Payment of Exercise | F | 34.25 | 840 | 28,770 | 26,595 | 27.4 K to 26.6 K (-3.06 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 2,420 | 0 | 27,435 | 25 K to 27.4 K (+9.67 %) |
| Mar 17 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Buy | P | 14.76 | 3,000 | 44,266 | 25,015 | 22 K to 25 K (+13.63 %) |
| Mar 17 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Buy | P | 14.76 | 3,000 | 44,266 | 25,015 | 22 K to 25 K (+13.63 %) |
| Mar 04 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Payment of Exercise | F | 33.23 | 1,235 | 41,039 | 10,765 | 12 K to 10.8 K (-10.29 %) |
| Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | A | 23.81 | 67,500 | 1,607,175 | 67,500 | |
| Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 11,250 | 0 | 23,250 | 12 K to 23.3 K (+93.75 %) |
| Jan 24 2019 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | A | 21.94 | 150,000 | 3,291,000 | 150,000 | |
| Jan 24 2019 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Page: 1